| 10:00 – 12:00 p.m. | ParallelFree Papers Session: Transplant | (Las Vegas Rooms) |
| Free Papers (FP – 05) Transplant | ||
| Abstract Number 140 – 149 | ||
| 140.) Role of primary resection for HCC under the era of liver transplantation | ||
| Toshiya Kamiyama, Kazuaki Nakanishi, MD, PhD, Hirofumi Kamachi, MD, PhD, Hideki Yokoo, MD, PhD, Munenori Tahara, MD, PhD, Hirofumi Toi, MD, PhD, Kenichiro Yamashita, MD, PhD, Masahiko Taniguchi, MD, PhD, Tomomi Suzuki, MD, PhD, Tsuyoshi Shimamura, MD, PhD, Hiroyuki Furukawa, MD, PhD, Michiaki Matsushita, MD, PhD, Satoru Todo, MD, PhD, Hokkaido University, Sapporo, Japan. | ||
| 141.) Improved Survival in Hepatocellular Carcinoma: Results of a Single Center Analysis of 501 Patients | ||
| David Kooby, MD, Vasili Egnatashvili, MD, Michael Graiser, PhD, Keith Delman, MD, William Wood, MD, Charles Staley, MD, Emory University, Atlanta, GA. | ||
| 142.) Tumor Size and Meld Score Predict Microvascular Invasion in Cirrhotic Patients with Hepatocellular Carcinoma | ||
| Swee H Teh, MD, B C Sheppard, MD, J Schwartz, MD, K G Billingsley, MD, S Cha, PhD, P S Kamath, MD, S L Orloff, MD, D M Nagorney, MD, Depart of Surgery, Oregon Health Sciences University, Portland, OR; Mayo Clinic, Rochester, MN. | ||
| 143.) Outcomes Analysis for 280 Patients with Cholangiocarcinoma Treated with Liver Transplantation Over an 18-year Period | ||
| Natasha S Becker, MD, Joel Rodriguez, MD, Neal R Barshes, MD, MPH, Christine O'mahony, MD, John A Goss, MD, Thomas A Aloia, MD, Baylor College of Medicine, Houston, TX. | ||
| 144.) Utilization of HTLV Positive Donor Livers For Transplantation | ||
| James V Guarrera, MD, Barbara Alkofer, MD, Jean C. Emond, MD, John F. Renz, MD, PhD, Columbia University, New York, NY. | ||
| 145.) Liver Transplantation In Latin America | ||
| Eduardo De Santibañes, MD, PhD, Martín Palavecino, MD, Diego Fernández, MD, Victoria Ardiles, MD, Juan Mattera, MD, Juan Pekolj, MD, PhD, Miguel Ciardullo, MD, Hospital Italiano, Buenos Aires, Argentina. | ||
| 146.) How to Balance the Risk for a Living Liver Donor-Or Is Death Always Preventable? | ||
| Burckhardt Ringe, MD, PhD, Humberto Soriano, MD, Ralph Petrucci, MD, William Meyers, MD, Drexel University College of Medicine, Philadelphia, PA. | ||
| 147.) Laparoscopically-Assisted Right Lobe Donor Hepatectomy: Results and Comparison with Open Lobe Donor Hepatectomy | ||
| Alan J Koffron, MD, Robert Kung, Greg Auffenberg, Michael Abecassis, MD, Northwestern University Medical School, Chicago, IL. | ||
| 148.) Venous reconstruction in living-donor hepatectomy | ||
| Atsushi Shimizu, MD, Yoshikazu Yasuda, MD, Masanobu Hyodo, MD, Taketo Fujiwara, MD, Yasunaru Sakuma, MD, Keisuke Yamashita, MD, Nobuyuki Hojo, MD, Hideo Chiba, MD, Makoto Ota, MD, Yoshito Nihei, MD, Hideo Nagai, MD, Jichi Medical School, Tochigi, Japan. | ||
| 149.) The effects of physical quality of life, time, and gender on change in symptoms of anxiety and depression after liver transplantation | ||
| Robert T. Russell, MD, Irene D. Feurer, PhD, Panarut Wisawatapnimit, C. Wright Pinson, MD, MBA, Vanderbilt University Medical Center, Nashville, TN. |